Name: Actinium Pharmaceuticals, Inc. (ATNM) Balance Sheet
Creator: FinSpry

Actinium Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Actinium Pharmaceuticals, Inc. (ATNM) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2018
Current Assets
Cash and Cash Equivalents	72.90	76.68	108.91	77.83	63.56	13.67
Cash & Short-Term Investments	72.90	76.68	108.91	77.83	63.56	13.67
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	1.60	1.59	0.07	0.06	1.32	0.00
Total Current Assets	74.51	78.26	110.94	79.75	64.93	14.33
Non-Current Assets
Property, Plant & Equipment (Net)	2.07	2.87	2.95	0.64	1.03	0.12
Long-Term Investments	0.32	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.32	0.31	0.30	0.00	0.44	0.39
Total Non-Current Assets	2.39	3.18	3.25	0.64	0.00	0.56
Total Assets	76.90	81.45	114.19	80.39	66.40	14.89
Current Liabilities
Accounts Payable	7.57	7.95	10.13	5.54	4.34	5.81
Short-Term Debt	1.16	0.00	0.00	0.00	0.00	0.00
Deferred Revenue	0.00	0.00	0.00	1.00	0.00	0.00
Other Current Liabilities	-0.58	0.00	0.00	1.00	0.00	0.00
Total Current Liabilities	8.15	8.49	10.63	6.84	4.77	6.06
Non-Current Liabilities
Long-Term Debt	0.99	1.57	2.08	0.00	0.00	0.01
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	35.99	36.57	37.08	0.00	0.00	0.01
Total Liabilities	44.14	45.07	47.71	6.84	5.08	6.08
Stockholders' Equity
Common Stock	0.03	0.03	0.03	0.02	0.02	0.00
Retained Earnings	-375.83	-337.58	-288.77	-255.75	-230.97	-186.86
Additional Paid-in Capital	408.55	373.93	355.22	329.27	0.00	195.55
Shares Outstanding	31.20	27.63	25.67	22.14	0.00	0.00
Total Stockholders' Equity	32.76	36.38	66.48	73.55	61.32	8.81
Total Liabilities & Equity	76.90	81.45	114.19	80.39	0.00	14.89